| 1 |
35498888 | Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy. | 2022 May |
1 |
| 2 |
34278996 | The Related Factors of Hyperuricemia in IgA Nephropathy. | 2021 Jul |
1 |
| 3 |
34392671 | Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience. | 2021 Aug 16 |
1 |
| 4 |
34895340 | Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy. | 2021 Dec 11 |
1 |
| 5 |
34912596 | Immunoglobulin A (IgA) Nephropathy: A Clinicopathologic Study in a Tertiary Care Center in Saudi Arabia. | 2021 Nov |
1 |
| 6 |
31606236 | Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression. | 2020 Mar |
1 |
| 7 |
32791815 | [Therapeutic effect of tonsillectomy on IgA nephropathy after kidney transplantation]. | 2020 Aug 11 |
1 |
| 8 |
33042337 | Estrogen receptor alpha expression in renal tissue and its relationship with prognosis in immunoglobulin A nephropathy. | 2020 |
1 |
| 9 |
33488671 | Periostin Contributes to Immunoglobulin a Nephropathy by Promoting the Proliferation of Mesangial Cells: A Weighted Gene Correlation Network Analysis. | 2020 |
2 |
| 10 |
30010903 | Plasma fractalkine levels are associated with renal inflammation and outcomes in immunoglobulin A nephropathy. | 2019 Sep 1 |
1 |
| 11 |
30880546 | Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response. | 2019 Nov |
1 |
| 12 |
29694420 | Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation. | 2018 |
1 |
| 13 |
31949578 | The association of the CMIP rs16955379 polymorphism with dyslipidemia and the clinicopathological features of IgA nephropathy. | 2018 |
1 |
| 14 |
28340830 | A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. | 2017 Apr |
1 |
| 15 |
26537358 | Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. | 2016 Aug |
1 |
| 16 |
27051593 | Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis. | 2016 Jun |
1 |
| 17 |
26249551 | IgA nephropathy with anti-neutrophil cytoplasmic antibody seropositivity. | 2015 Sep |
1 |
| 18 |
24046272 | IgA nephropathy factors that predict and accelerate progression to end-stage renal disease. | 2014 Apr |
1 |
| 19 |
24998891 | Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria. | 2014 Jul 7 |
1 |
| 20 |
23837450 | Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. | 2013 Jul 9 |
1 |
| 21 |
25340125 | Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience. | 2013 |
1 |
| 22 |
27293567 | Metabolic syndrome and other cardiovascular risk factors associated with the progression of IgA nephropathy. | 2013 Aug |
1 |
| 23 |
21725924 | Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy. | 2012 Mar-Apr |
1 |
| 24 |
22809602 | [A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children]. | 2012 Jul |
1 |
| 25 |
21402675 | Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. | 2011 Oct |
2 |
| 26 |
19937361 | Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy. | 2010 Feb |
1 |
| 27 |
21163122 | Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. | 2010 Nov |
1 |
| 28 |
19169006 | Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy. | 2009 |
1 |
| 29 |
19194560 | Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patients. | 2009 Jan |
1 |
| 30 |
19420105 | A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). | 2009 Dec |
4 |
| 31 |
18498720 | The influence of two megsin polymorphisms on the progression of IgA nephropathy. | 2008 |
1 |
| 32 |
18771467 | Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions. | 2008 Dec |
2 |
| 33 |
17360238 | Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. | 2007 May |
1 |
| 34 |
16504678 | IgA nephropathy in kidney allograft recipients-therapeutic perspective. | 2006 Jan-Feb |
1 |
| 35 |
14717912 | Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. | 2004 Feb |
4 |
| 36 |
15480901 | The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. | 2004 Sep |
1 |
| 37 |
15481848 | Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy. | 2004 Sep |
1 |
| 38 |
12759582 | Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. | 2003 |
1 |
| 39 |
12812644 | [Significance of vascular lesions in IgA nephropathy and their influencing factors, a study of 1,005 cases]. | 2003 Feb 25 |
1 |
| 40 |
12138282 | Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy. | 2002 Aug |
1 |
| 41 |
12439840 | [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review]. | 2002 Sep-Oct |
1 |
| 42 |
11157380 | Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy. | 2001 Feb |
1 |
| 43 |
11316238 | Corticosteroid therapy in patients with IgA nephropathy and impaired renal function. | 2001 Mar |
1 |
| 44 |
11499564 | Role of proteinuria reduction in the progression of IgA nephropathy. | 2001 May-Jul |
1 |
| 45 |
9623340 | [Significance of inflammatory cytokines in the pathogenesis of IgA nephropathy]. | 1998 Mar-Apr |
1 |
| 46 |
9105763 | Expression of thromboxane synthase in kidney tissues from patients with IgA nephropathy. | 1997 Mar |
1 |
| 47 |
9214406 | Demonstration of the proliferation marker Ki-67 in renal biopsies: correlation to clinical findings. | 1997 Jul |
1 |
| 48 |
9274837 | The renal hemodynamic response to an oral protein load is normal in IgA nephropathy. | 1997 |
1 |
| 49 |
9489955 | The consequences for renal function of the glomerular deposition of PAS positive material in proliferative glomerulopathies. A quantitative study. | 1997 Dec |
1 |
| 50 |
8943482 | Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. | 1996 Dec |
1 |